Frank L. Jaksch Jr - Jun 24, 2025 Form 4 Insider Report for Niagen Bioscience, Inc. (NAGE)

Role
Director
Signature
/s/ Jeong James Lee, Attorney-in-Fact
Stock symbol
NAGE
Transactions as of
Jun 24, 2025
Transactions value $
$0
Form type
4
Date filed
6/25/2025, 08:23 PM
Previous filing
Dec 13, 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Jaksch Frank L Jr Director 10900 WILSHIRE BLVD. SUITE 600, LOS ANGELES /s/ Jeong James Lee, Attorney-in-Fact 2025-06-25 0001437237

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NAGE Stock Option (right to buy) Award $0 +20K $0.00 20K Jun 24, 2025 Common Stock 20K $14.13 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Option vests 100% on June 24, 2026.